6550--Lexington Ortho Clinical Diag - Blood Bank
ID: 36C24925Q0050Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF249-NETWORK CONTRACT OFFICE 9 (36C249)MURFREESBORO, TN, 37129, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/d043d448bb784c6bbbab57cf779e7141/view
Timeline
    Description

    The Department of Veterans Affairs, through the Network Contracting Office 9, intends to award a sole source contract to Ortho Clinical Diagnostics for the provision of specific reagents and consumables necessary for the ORTHO Vision Swift ID-Micro Typing System at the Lexington VA Medical Center. This procurement is critical as Ortho Clinical Diagnostics is the only manufacturer capable of supplying products that are compatible with the existing equipment, ensuring the effective operation of the blood bank services. Interested vendors are invited to submit capability statements by 10:00 a.m. CT on November 15, 2024, to james.moore20@va.gov; however, this notice does not constitute a competitive solicitation, and the government retains discretion over the procurement process.

    Point(s) of Contact
    James MooreContract Specialist
    email only
    james.moore20@va.gov
    Files
    Title
    Posted
    36C24925Q0050.docx
    The Department of Veterans Affairs, through the Network Contracting Office 9, is issuing a special notice regarding a sole source procurement for the Lexington VA Medical Center. The intent is to award a contract to Ortho Clinical Diagnostics for the supply of specific reagents and consumables required for their ORTHO Vision Swift ID-Micro Typing System. Ortho Clinical Diagnostics is the only manufacturer capable of providing the necessary products that are compatible with the existing equipment at the Lexington VAMC. The notice clarifies that while alternative FDA-approved products exist, they are incompatible with the ORTHO Vision system. Interested vendors are invited to submit capability statements by November 15, 2024, but this notice does not constitute a competitive solicitation. The document emphasizes that the government retains discretion over the procurement process, including the decision not to compete based on the responses received. This procurement falls under the Veteran's First Contracting Program and does not meet the Rule of Two criteria. The document outlines requirements for response submissions, including company details and authorization from the manufacturer.
    Lifecycle
    Title
    Type
    6550--Lexington Ortho Clinical Diag - Blood Bank
    Currently viewing
    Special Notice
    Similar Opportunities
    6640--06 BACT/ALERT VIRTUO Blood Culture System, Consumables, and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to establish a sole-source Indefinite Delivery Indefinite Quantity (IDIQ) contract for the BACT/ALERT VIRTUO Blood Culture System, including necessary consumables and support services, to be utilized across multiple laboratories within VISN 6. This procurement aims to ensure the provision of a fully automated blood culture testing system, which is critical for healthcare services provided to veterans, with the contract expected to commence on November 29, 2024. The decision to pursue a sole-source contract with BioMerieux Incorporated follows market research indicating that these specialized items are exclusively available from the original equipment manufacturer, thereby avoiding delays and additional costs. Interested parties may express their capabilities to Contract Specialist Stephanie McElmore via email by November 19, 2024, and should clearly indicate their business status regarding size and ownership.
    6630--Notice of Intent - Sole Source Bridge Contract - Integrated Chemistry CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source bridge contract to Beckman Coulter, Inc. for an integrated chemistry Cost-Per-Reportable Result (CPRR) program. This procurement includes equipment rental and maintenance services, as well as 103 different chemistry and immunochemistry tests, ensuring the provision of necessary reagents, controls, and consumables for the Central Texas Veterans Health Care System. The contract is crucial for maintaining laboratory operations during the transition to new equipment analyzers, with the anticipated period of performance from January 15, 2025, to October 14, 2025. Interested parties may submit capability statements for consideration within seven days of this notice, after which the contract will be finalized with Beckman Coulter, Inc. if no other responses are received. For further inquiries, contact Kathryn Prose at kathryn.prose@va.gov or (254) 217-2835.
    6550--Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to negotiate a sole source contract with Microgenics Corporation for the procurement of FDA-approved Microgenics DRI Ecstasy Plus Assay Reagent, which is essential for use with Beckman AU480 Analyzers at the Minneapolis VA Medical Center. This contract action is being pursued under the authority of FAR 13.106-1, which allows for sole source awards when only one source is available to meet the government's requirements. The reagents are critical for in-vitro diagnostic testing, ensuring accurate and timely results for patient care. Interested vendors who believe they can meet the requirements are invited to submit a capability statement by 12:00 PM Central Time on January 9, 2025, to Alisha Milander at Alisha.Milander@va.gov, with all submissions needing to include registration details in the System for Award Management (SAM).
    6550--NEW | CTX ABL 90 Reagents and Consumables
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply reagents and consumables for venous and arterial blood gas testing using ABL90 analyzers at the Central Texas Veterans Health Care System. The procurement aims to establish a firm-fixed price, indefinite delivery/indefinite quantity (IDIQ) contract for a five-year period, ensuring compliance with the Buy American Act. This acquisition is crucial for enhancing medical testing services for veterans, as the reagents and consumables will support the operation of three ABL90 analyzers recently purchased for the facility. Interested parties must respond to the Request for Information (RFI) by January 10, 2025, and can direct inquiries to Contract Specialist Ognian D. Ivanov at Ognian.Ivanov@va.gov.
    J065--O-Arm Service Agreement Maintenance
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract for an O-Arm Service Agreement Maintenance to MEDTRONIC, Inc., which is recognized as the authorized distributor and service center for O-Arm equipment. This procurement aims to secure maintenance services essential for the operation and reliability of medical equipment used within the Veterans Health Administration. Interested vendors are invited to submit an authorized distribution letter and a capability statement to the contracting specialist, Matt Lee, at matthew.lee5@va.gov, within five days of this notice; otherwise, the contract will be awarded to MEDTRONIC without further notice. The procurement is governed by statutory authorities allowing for limited competition under the Federal Acquisition Regulation (FAR), ensuring compliance while streamlining the contracting process.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    Lab Reagents for Pathology Dept. at WRNMMC
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Roche Diagnostics Corporation for the procurement of specialized lab reagents and consumables necessary for molecular diagnostics testing in the Pathology Department at Walter Reed National Military Medical Center (WRNMMC). This procurement is critical for testing viral pathogens and is supported under the authority for non-competitive purchases, as Roche is the sole supplier of the proprietary materials required for use with the existing Roche medical equipment at WRNMMC. Interested parties may submit their qualifications by January 10, 2025, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil. The government retains discretion over the contract award process and is not obligated to seek competitive bids despite any expressions of interest received.
    6640--NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract to Illumina, Inc. for the provision of molecular testing reagents required by the Minneapolis VA Health Care System. This procurement involves a Firm Fixed Price Purchase Order for a base year plus four option years, specifically for next-generation sequencing reagents that are compatible with the VA's existing Illumina sequencers. The sole-source justification is based on the fact that Illumina is the only authorized supplier for these specialized reagents, with no alternative products approved for use on the VA's equipment. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by January 10, 2025, to the Contracting Officer, Traci Johannes, at traci.johannes@va.gov.
    J065--Hologic Dexa - Emergency Repair | NCO 4
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Hologic, Inc. for emergency repairs to a Bone Density Scanner at the Lebanon VA Medical Center. This urgent procurement aims to ensure operational continuity and safety, as the facility relies exclusively on this equipment for density imaging critical to patient care. The contract will require compliance with federal standards, the use of OEM parts, and completion of repairs within 30 days of award. Interested firms may submit capability statements by January 6, 2025, at 10 AM EST, with all communications directed to Contract Specialist Christine Shockley at Christine.Shockley@va.gov.
    6640--VISN Blanket Purchase Agreement NEW Coagulation CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a Blanket Purchase Agreement (BPA) to acquire coagulation analyzers, related equipment, reagents, and services for various VA medical facilities. The procurement aims to ensure the availability of high-quality coagulation testing capabilities, which are critical for patient diagnosis and treatment, over a five-year term from February 1, 2025, to January 31, 2030. This opportunity emphasizes compliance with federal guidelines, including cybersecurity measures for medical devices, and prioritizes service-disabled veteran-owned businesses. Interested vendors must submit their proposals by January 6, 2025, and can contact Contracting Specialist Lindsey M Zwaagstra at Lindsey.Zwaagstra@va.gov for further information.